Clinical Trial Update: Botox as a Treatment for Chronic Male Pelvic Pain Syndrome [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating Botox (onabotulinumtoxinA) for chronic prostatitis/chronic pelvic pain syndrome was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostatitis Chronic Pelvic Pain Syndrome

Drugs mentioned

• Botox (OnabotulinumtoxinA)

Snippet

Sponsor: University of Washington | Conditions: Chronic Male Pelvic Pain Syndrome | Phase 4 | Status: TERMINATED